Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Dissemination of CPRIT-Funded Cancer Control Interventions

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be able to develop one or more "products" based on the results of the CPRIT-funded intervention. The proposed project should also identify and assist others to prepare to implement the intervention and/or prepare for grant funding. 

Award: Maximum of $450,000; Maximum duration of 36 months. 

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release May 06, 2022
Application Receipt June 02, 2022 - August 31, 2022
Application Review September 2022 - February 2023
Award Notification February 2023

Primary Prevention of Cancer

Program Prevention
RFA Status Open
Description

This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served.

Award: Maximum of $1M for new projects and $2.5M for expansion projects; maximum duration of 60 months

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release May 06, 2022
Application Receipt June 02, 2022 - August 31, 2022
Application Review September 2022 - February 2023
Award Notification February 2023

Cancer Screening and Early Detection

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers.

Award: Maximum of $1M for new projects and $2.5M for expansion projects; maximum duration of 60 months

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release May 06, 2022
Application Receipt June 02, 2022 - August 31, 2022
Application Review September 2022 - February 2023
Award Notification February 2023

Individual Investigator Research Awards

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release January 14, 2022
Application Receipt March 16, 2022 - June 08, 2022
Application Review June 2022 - February 2023
Award Notification February 2023

Individual Investigator Research Awards for Cancer in Children and Adolescents

Revised: 03/16/2022

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release January 14, 2022
Application Receipt March 16, 2022 - June 08, 2022
Application Review June 2022 - February 2023
Award Notification February 2023

Individual Investigator Research Awards for Clinical Translation

Revised: 03/16/2022

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications that propose innovative cancer clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Clinical trial must be planned to begin when contract is awarded.

Award: Up to $500,000 per year. Maximum duration: 4 years. Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release January 14, 2022
Application Receipt March 16, 2022 - June 08, 2022
Application Review June 2022 - February 2023
Award Notification February 2023

Individual Investigator Research Awards for Computational Systems Biology of Cancer

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection). 

Award: Up to $400,000 in total costs per year for up to 3 years. Exceptions permitted if  extremely well justified.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release January 14, 2022
Application Receipt March 16, 2022 - June 08, 2022
Application Review June 2022 - February 2023
Award Notification February 2023

Individual Investigator Research Awards for Prevention and Early Detection

Revised: 03/16/2022

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer are strongly encouraged. 

Award: Up to $400,000 per year. Exceptions permitted if extremely well justified; maximum duration: 5 years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release January 14, 2022
Application Receipt March 16, 2022 - June 08, 2022
Application Review June 2022 - February 2023
Award Notification February 2023

Texas Regional Excellence in Cancer Award (TREC)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research funding.

Award: Up to $6,000,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release September 27, 2021
Application Receipt May 16, 2022 - September 08, 2022
Application Review September 2022 - November 2022
Award Notification January 2023